To investigate the effect of betulinic acid (BA) on the proliferation, apoptosis and cell cycle of gastric adenocarcinoma cell AGS in vitro and elucidate the underlying mechanisms. Methods: The effect of BA on the proliferation of AGS cells was measured by using 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium (MTT) assay. Apoptosis was analyzed by using Annexin V-fluorescein isothiocyanate (FITC)/propidium iodide (PI) double-labeled flow cytometry (FCM) and Hoechst 33258 staining. The influence of BA on cell cycle of AGS cells was tested by PI staining. Both FCM and reverse transcription-PCR (RT-PCR) technologies were applied to detect the expression of Hiwi and Cyclin B1. Results: BA exhibited significant cell proliferation inhibition, as well as its potency of inducing apoptosis in AGS cells in vitro in a timeand dose-dependent manner. The IC 50 value for 24 h was 18.25 μg/mL (95% confidence interval: 15.16 to 27.31 μg/mL). Cells treated with BA showed increased cell population in G 2 /M phase, with decreased S phase population. The expression of Hiwi and Cyclin B1 was down-regulated in BA-treated AGS cells in a dose-dependent manner. Conclusion: BA exerted potent effect on growth inhibition, G 2 /M cell cycle arrest and induction of apoptosis in AGS cells in vitro, possibly associated with the down-regulation of Hiwi and its downstream target Cyclin B1 expression. The potent antitumor capacity of BA suggested that it could be a promising new experimental anticancer agent in human gastric adenocarcinoma treatment.
Introduction
Betulinic acid (BA), isolated from birch trees, is a natural pentacyclic triterpene which has demonstrated anti-HIV, anti-HBV and anti-malarial abilities [1] [2] [3] . In addition, BA is believed to play an important role in delaying or preventing carcinogenesis. It was proved to be able to kill melanoma cells via induction of apoptosis [4] . Many other cancer cell lines derived from a variety of different malignancies such as leukemia, prostate, ovarian, breast, lung, and colon cancers were also found to be sensitive to apoptosis induced by BA [5] [6] [7] . BA did not induce apoptosis in normal cells. And in animal studies, no adverse effect was observed at concentrations up to 100 mg/kg body weight [8] . However, whether BA can inhibit the proliferation of human gastric adenocarcinoma AGS cell remains unknown.
The cytotoxic mechanism of BA, which is linked to its alteration in cell apoptosis and cell cycle, is controversial. Treatment with BA resulted in up-regulation of the pro-apoptotic Bax in neuroblastoma, glioblastoma and melanoma cells, whereas anti-apoptotic Bcl-XS was found at elevated levels in BA-treated neuroblastoma cells [9] [10] [11] . An increase in Bcl-2 protein levels was reported in glioblastoma cells [10] . BA also triggered up regulation of Mcl-1, another anti-apoptotic Bcl-2 family protein, in melanoma cells, whereas no changes in Mcl-1 levels were detected in squamous cell carcinoma cells [11] [12] [13] . While BA was found to reduce the expression of p21 protein in melanoma cells, an increase of p21 protein was observed upon treatment with BA in glioblastoma cells [10, 14] . Therefore how BA-mediated cell cycle changes are linked to its antitumor activity remains to be addressed. Since bcl-X L , p21, Cyclin D1, and Cdc2-Cyclin B complex expression modulated by BA are also regulated by Hiwi [15] [16] [17] , it is very possible that BA exerts its antitumor effect through directly affecting a major target Hiwi and then indirectly impacting other factors.
The Piwi family comprises Hili, Hiwi1, Hiwi2 and Hiwi3 in humans, Mili, Miwi and Miwi2 in mice and Piwi, Aubergine
Acta Pharmacologica Sinica npg (Aub) and Ago3 in flies. This family is united via a common domain structure -PAZ and PIWI -and a common molecular mechanism: short, guide-strand-mediated target recognition and, in the majority of cases, a capacity for target slicing. Genetic and biochemical studies first linked Piwi proteins to signaling processes that affect cellular differentiation and development [18] . In addition, numerous groups have shown that Piwi proteins function as part of the RNAi machinery to mediate posttranscriptional gene, chromatin silencing and cell cycle regulation [17, 19] . Moreover, Piwi proteins are proved to serve as effector molecules that provide specificity in gene-silencing pathways [20] . Dicer processed micro-RNAs or small interfering RNAs (siRNA) bind Piwi proteins to form ribonucleoprotein complexes termed RNA induced silencing complexes (RISCs), which are thought to mediate mRNA degradation, translational repression, or chromatin silencing in a homology-dependent manner [20] . It has been estimated that Piwi protein-dependent RNAi controls the expression of more than 30% of genes in the human genome [20] .
It has recently been observed that seminoma tumors are often associated with increased levels of Hiwi mRNA [21] . Coincidentally, Hiwi was first reported as a gene that is expressed in undifferentiated haematopoietic stem cells, but not in differentiated cells [22] . Likewise, the expression of the D melanogaster orthologue of Hiwi, Piwi, had previously been reported to promote mitosis in stem cells [18] . In addition, the chromosomal locus 12q24.33 that includes the Hiwi gene has been linked to testicular germ cell tumors [23] . Conversely, deletion of this region is associated with hypogonadism [24] . Together, these observations are consistent with a scenario in which overexpression of certain Piwi proteins is associated with increased mitosis in undifferentiated cells. So Hiwi plays a critical core role in the carcinogenesis and can be served as a new therapeutic target for human cancer. Mechanisms regulating Hiwi may provide novel opportunities for anti-tumour drug development.
In this study, we examined the efficiency of BA on gastric adenocarcinoma AGS cell proliferation and apoptosis, and explored its relationship with the regulation of Hiwi and Cyclin B1 gene expression. We demonstrated that BA downregulated the expression of Hiwi and its downstream targets Cyclin B1 in AGS cells, accompanied by apoptosis induction, cell cycle arrest and proliferation inhibition. 100 U/mL penicillin, 100 μg/mL streptomycin and placed in a humidified incubator with 95% air and 5% CO 2 at 37 ºC.
Materials and methods

Reagents
MTT assay
The effect of BA on proliferation of AGS cells was examined using a MTT assay. AGS cells were maintained in DMEM medium until mid-log phase and plated at a density of 1×10 4 cells per well in 96-well plate in triplicates. Cells were allowed to attach overnight, then incubated with various concentrations of BA for 24 h, 36 h and 48 h, respectively. PBMCs were plated at a density of 5000 cells per well in 96-well plate as control cells, followed by adding BA immediately. The final concentrations of BA were 9, 12, 15, 18 and 21 µg/mL, while the group dissolved with maximal DMSO concentration served as the control. After incubation, 20 μL MTT solution (5 mg/mL) was added and the cells were further incubated at 37 ºC for 4 h. The supernatant was discarded and 150 μL DMSO was added. The plate was gently shaken until the blue crystals were dissolved. Absorbance (A) at 570 nm wavelength was read using a 96-well multiscanner autoreader (Biotech Instruments, NY, USA). Relative cell proliferation was calculated with the following formula: cell proliferation inhibition of =[1-( A of experimental samples/A of the control)]×100%.
Annexin V-FITC/PI double-labeled flow cytometry
For detection of apoptotic cells treated with BA, the expression of Annexin V-FITC and exclusion of PI were detected by twocolor flow cytometry (FCM). Cells incubated with different concentrations of BA (9, 12, 15 and 18 μg/mL) for 24 h were collected and washed with PBS, then resuspended in 100 μL binding buffer. Samples were incubated with 5 μL Annexin V-FITC in dark for 10 min at 4 ºC, then volume was adjusted to 500 µL with binding buffer. PI (5 μL) was added and samples were incubated for another 10 min at 4 ºC. Fluorescence was measured with a flow cytometer (Becton Dickinson, USA).
Hoechst 33258 staining Nuclear fragmentation of AGS cells treated with 15 μg/mL BA was visualized by Hoechst 33258 staining. AGS cells were plated in 6-well plates at the density of 1×10 5 cells. After being allowed to attach overnight, cells were treated with 15 µg/mL BA for 24 h and collected by trypsin digestion method. Cells were fixed in 4% paraformaldehyde for 10 min at room tem-
Acta Pharmacologica Sinica npg perature and re-suspended in 50 μL PBS before deposition on poly lysine-coated cover slips. After 30 min, the adhered cell were permeabilized with 0.1% Triton X-100 for 5 min at 4 ºC and incubated with Hoechst 33258 for 30 min at room temperature. Cover slips were rinsed with PBS, mounted on slides with glycerol, and imaged with an Olympus BH-2 fluorescence microscope (Tokyo, Japan).
Cell cycle analysis AGS cells treated with BA at various concentrations were collected, washed with PBS, and then suspended in 70% ethanol at 4 ºC overnight. Cells were incubated with 20 μL 0.1% RNase A for 15 min at room temperature, and incubated with 50 μg/mL PI for 15 min. DNA content was examined by using FCM and the cell cycle analysis was performed using CellQuest software (Becton Dickinson, USA).
Detection of the expression of Hiwi and Cyclin B1 protein AGS cells at 1×10 6 treated respectively with 0, 9, 12, 15 and 18 μg/mL BA for 24 h were collected, washed with PBS, and then fixed in 4% paraformaldehyde for 10 min at room temperature. After amplification, 5 μL aliquots of products were electrophoresed on 1.7% agarose gel. DNA bands were quantified using Smart View Bio-electrophoresis Image Analysis System. The ratio between Hiwi (or Cyclin B1) and β-actin band density represented the relative expression level of the target gene.
Statistical analysis
All experiments were repeated three times. All data were expressed as mean±SD and processed by SPSS 13.0 statistical software for Window. One-way ANOVA and Student-Newman-Keuls (SNK) test were applied for comparison between each group and P<0.05 was considered to be statistically significant.
Results
Effect of BA on proliferation of AGS cells The cytotoxicity of BA to AGS cells at 0, 9, 12, 15, 18 and 21 μg/mL for various time was measured using MTT assay. AGS cells were treated with various concentrations BA for 0, 24, 36 and 48 h, respectively, which resulted in a significant decrease of cell viability of AGS cells in a dose-and time-dependent manner (Figure 1) Effect of BA on apoptosis of AGS cells Apoptosis rate of AGS cells treated with various concentrations of BA (0, 9, 12, 15 and 18 μg/mL) for 24 h was analyzed by Annexin V-FITC/PI double-labeled flow cytometry. The degree of early apoptosis was quantitatively expressed as a percentage of the Annexin V-FITC-positive but PI-negative cells, while late apoptosis was quantitatively expressed as a percentage of the Annexin V-FITC-positive and PI-positive cells. The apoptosis rate was the sum of early apoptosis and late apoptosis. There was little binding of Annexin V-FITC in untreated and 9 μg/mL BA treated AGS cells (Figure 2) . However, after treatment of cells with BA at 12, 15 and 18 μg/mL for 24 h, the apoptosis rate was 9.90%±0.44%, 29.13%±1.57% 
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Acta Pharmacologica Sinica npg and 48.96%±2.55%, respectively, which were statistically higher than the control 3.47%±0.21% ( Figure 2 ). The nuclear fragmentation of AGS cells treated with 15 μg/mL BA for 24 h was stained by Hoechst 33258 (Figure 3 ). Apoptotic body containing nuclear fragments was found in BA-treated cells, the nuclear envelope appeared lytic and the cytoplasm shrunk. In contrast, the cells in the culture without BA showed normal cell nuclei morphology.
Cell cycle analysis
After incubation with BA, AGS cells were analyzed using FCM to analyze alterations in cell cycle distribution. DNA content distribution in AGS cells was changed after 24 h treatment with various concentrations of BA (0, 9, 12, 15, and 18 μg/mL) ( Figure 4 ). As the dose of BA increased, the percentage of cells in G 2 /M phase was increased with a concomitant sub-G 1 apoptotic peak, and that in S phase decreased in a dose-dependent manner. There were minimal changes in G 0 /G 1 phase cell population. As compared with control sample, the ratio of apoptotic cells in BA-treated samples was higher. This sug- 
Expression of Hiwi and Cyclin B1 protein in AGS cells
Extensive investigations have implicated that the overexpression of Hiwi is known for tumor cell growth and survival response, which performs multiple functions ranging from posttranscriptional gene, chromatin silencing and cell cycle regulation. The present study and other findings have demonstrated that BA potently inhibited cell proliferation and induced apoptosis of AGS cells and many other cell lines. We therefore hypothesized that BA might be disrupting these cellular processes by primarily inhibiting the Hiwi gene. To test this hypothesis, we first examined whether constitutive deregulation of Hiwi existed in AGS cells. Since CyclinB1, which is under the control of Piwi protein, also plays a key role in tumorigenesis including gastric cancer, we further investigated whether BA could also inhibit Cyclin B1 activity in AGS cells. FCM was used to detect the expression of Hiwi and Cyclin B1 protein in AGS cells, and the mean fluorescence intensity represented the expression levels of Hiwi and Cyclin B1 protein.
The wave crest representing the fluorescence intensity shifted left after AGS cells were treated with BA for 24 h ( Figure 5A ). In this experiment, the mean fluorescence intensity value of Hiwi protein in untreated group was 1405±21, while that in the groups treated with 9, 12, 15 and 18 μg/mL BA was downregulated to 1159±17, 681±13, 645±10 and 621±8, respectively ( Figure 5B ). The Cyclin B1 protein expression in AGS cells was also down-regulated by BA. The mean fluorescence intensity of Cyclin B1 in the control group was 512±14, while that in the groups treated with 9, 12, 15 and 18 μg/mL BA was 447±13, 415±11, 384±8 and 351±9, respectively ( Figure 5C ). The results indicated that BA down-regulated the expression of Hiwi and Cyclin-B1 protein in a dose-dependent manner.
Detection of Hiwi and Cyclin B1 mRNA by RT-PCR
In order to identify whether the decrease of Hiwi and Cyclin B1 proteins was mediated at the transcriptional level by a decrease of Hiwi and Cyclin B1 mRNA expression, or at the post-translation level, we performed reversed transcriptase PCR (RT-PCR). Highest expression of Hiwi mRNA was detected in control group, with a mean value of 1.319±0.045 as compared with β-actin. After incubation with 9, 12, 15, 18 and 21 μg/mL BA for 24 h, Hiwi/β-actin ratio in AGS cells was decreased to 0.822±0.094, 0.674±0.065, 0.506±0.041, 0.272±0.023 and 0.209±0.027, respectively ( Figure 6A , Figure 6C ). The Cyclin B1 mRNA expression was also down-regulated. The expression level of Cyclin B1 mRNA in 9 µg/mL BA-treated group was not significantly different from that in the control ( Figure 6B , Figure 6D ).
Discussion
BA is a natural pentacyclic triterpene isolated from birth trees. It is a very potent anticancer compound that is capable of killing a plethora of tumor cells. However, antitumor activity and action mechanism of BA still remains elusive. Our results indicated that BA possessed significant cytoxitity against AGS cells in a dose-and time-dependent manner, and IC 50 for 24 h was 18.25 μg/mL (95% confidence interval: 15.16 to 27.31 μg/mL), well below the established tolerance level. BA also induced distinct G 2 /M phase arrest and apoptosis in AGS cells, accompanied with typical apoptotic morphological changes. It have been revealed numerous pro-apoptosis and cell cycle proteins (eg, Cyclin B1, CyclinD1 and Bcl-x L ) were targeted by BA [15] [16] [17] . Because Bcl-x L , Cyclin D1 and Cyclin B1 gene expression modulated by BA is regulated by Piwi protein, we investigated whether the anticarcinogenic effect of BA was mediated through modulation of Hiwi and Hiwi-regulated gene products. The significant decrease of the levels of both Hiwi mRNA and protein in AGS cells upon BA treatment strongly supported this hypothesis. BA also modulated Piwidependent gene products Cyclin B1 which are believed to be important for apoptosis and G 2 /M arrest and serve as a common target for cancer drug development. It suggests that BA is an effective anti-gastric cancer reagent through the ability of inducing growth-arrest and apoptosis and cell cycle arrest via the downregulation of Hiwi.
Hiwi is human subfamily of Piwi family. PPD (PAZ Piwi domain) proteins form the core of RNA-induced silencing complexes (RISCs), which is required for gene silencing. Previous studies have shown that Piwi performs multiple functions ranging from epigenetic programming and repression of transposition to post transcriptional regulation [25, 26] . Moreover, it has recently become evident that PPD proteins and Dicer also function in siRNA-independent and dependant pathways that regulate cell cycle event [27] . High-level expression of Hiwi mRNA is related with high risk of tumor-related death in soft-tissue sarcomas patients [28] . It had been reported that Hiwi expression was higher in gastric cancers than in normal mucosa or in mucosa with atrophic gastritis or intestinal metaplasia, and the suppression of Hiwi by antisense or RNAi inhibited the growth of gastric cancer cells and induced cell cycle arrest in G 2 /M phase [29] . These studies suggest that Hiwi might be an attractive target for future gastric cancer therapeutic drugs. Consistent with the above observation, we also found Hiwi was overexpressed in AGS cells. Moreover, this is the first report to suggest that BA could downregulate the levels of both Hiwi mRNA and protein, which inhibited growth, induced apoptosis and cell cycle arrest of AGS cells.
Overexpression of the Piwi in yeast resulted in cell cycle delay at the G 2 /M boundary [17] . For example in Drosophila, altering the expression level of Piwi leads to changes in the proliferation rate of germline stem cells [18] . Furthermore, the Piwi signaling network exhibits cross talk with the Hedgehog signaling machinery [30] , a developmental patterning system that influences the cell cycle through the actions of Patched1 on cyclin B1 [31] . Piwi is required for regulated hyperphosphorylation of the cyclin-dependent kinase Cdc2 [32] , which controls the transition from the G 2 phase of the cell cycle to mitosis through binding with Cyclin B. Inhibitory phosphorylation of Cdc2 is required to prevent the onset of mitosis in situations where damaged or unreplicated DNA is present [33] . In our study, BA induced cell cycle arrest at G 2 /M and simultaneously decreased the expression of Hiwi in AGS cells in a dosedependent manner. We could infer that BA down-regulated Hiwi through inhibiting Cyclin B1. In agreement with this hypothesis, we found that BA treatment could strongly inhibit CyclinB1 concurrently with Hiwi.
Taken together, our results demonstrated that BA presented potent effect on growth inhibition, G 2 /M cell cycle arrest and induction of apoptosis in AGS cells in vitro via down-regulating Hiwi and Cyclin B. Based on the outcome of this study, it is suggested that Hiwi might be a novel target for gastric cancer treatment and BA could be used as a potent agent for the management of gastric cancer. However, further studies are needed to establish a cause-and-effect relationship between Hiwi/Cyclin B pathway and BA effect. Furthermore, it will also be important to validate these findings in the in vivo animal models, which could better relate to human situations. 
